524636 — Oxygenta Pharmaceutical Balance Sheet
0.000.00%
- IN₹3.37bn
- IN₹3.97bn
- IN₹396.42m
Annual balance sheet for Oxygenta Pharmaceutical, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | C2022 March 31st | C2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 1.18 | 4.45 | 1.56 | 1.06 | 1.01 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 9.02 | 16.5 | 15.8 | 102 | 73.6 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 67.7 | 159 | 95.6 | 250 | 241 |
Net Property, Plant And Equipment | 114 | 170 | 203 | 279 | 294 |
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 186 | 339 | 312 | 543 | 632 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 170 | 188 | 80.7 | 329 | 337 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 596 | 719 | 658 | 1,005 | 833 |
Common Stock | |||||
Other Equity | |||||
Total Equity | -409 | -380 | -346 | -462 | -201 |
Total Liabilities & Shareholders' Equity | 186 | 339 | 312 | 543 | 632 |
Total Common Shares Outstanding |